Skip to content

Falls in people post-Guillain-Barré syndrome in the United Kingdom: A national cross-sectional survey of community based adults Guillain-Barré syndrome (GBS) has several enduring effects that can lead to further harm and/or lower quality of life. These effects include falling and body pain, neither of which have been fully explored. This study aims to examine the […] Read More

One-off PHB for hospital discharge

Posted on

One-off PHB for hospital discharge An interesting development in the drive to get patients home from hospital more quickly – a one-off PHB (Personal Health Budget) for hospital discharge. One of the complicating factors around care of people who are seriously ill with COVID is the number of patients who can’t be discharged from hospital, […] Read More

Please read the Small Charities Coalition weekly newsletter from 16th November 2021, containing their latest COVID-19 update: SCC’s Newsletter 16th November (

The antiviral Lagevrio (molnupiravir) is safe and effective at reducing the risk of hospitalisation and death in people with mild to moderate COVID-19 who are at increased risk of developing severe disease, the Medicines and Healthcare products Regulatory Agency (MHRA) announced today. This follows a rigorous review of its safety, quality and effectiveness by the […] Read More

The risks of developing neurological complications following Covid-19 infection ‘are much greater’ than those associated with Covid-19 vaccinations, according to a UK-based study led by the University of Oxford. In one of the most extensive population-based studies to examine the risk of developing adverse neurological reactions in response to Covid vaccinations, the researchers found neurological […] Read More

Emerging reports of rare neurological complications associated with COVID-19 infection and vaccinations are leading to regulatory, clinical and public health concerns. We undertook a self-controlled case series study to investigate hospital admissions from neurological complications in the 28 days after a first dose of ChAdOx1nCoV-19 (n = 20,417,752) or BNT162b2 (n = 12,134,782), and after a SARS-CoV-2-positive test (n = 2,005,280). There […] Read More

Winter Vaccinations

Posted on

Read the latest NHS guidance on vaccinations this winter: